Koyfin Home > Directory > Health Care > Inovio Pharma > Net Debt / EBITDA

Inovio Pharma Net Debt / EBITDA Chart (INO)

Inovio Pharma annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Inovio Pharma Net Debt / EBITDA for the quarter ending June 06, 2020 was $2m a 99.55% increase of 2m year over year
  • Inovio Pharma Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $3m a 99.71% increase of 3m year over year
  • Inovio Pharma Annual Net Debt / EBITDA for 2019 was $0m a 1,026.46% decrease of -1m from 2018
  • Inovio Pharma Annual Net Debt / EBITDA for 2018 was $1m a -72.17% decrease of -1m from 2017
  • Inovio Pharma Annual Net Debt / EBITDA for 2017 was $2m a 9.99% increase of 0m from 2016
Other Ratios Metrics:
  • Inovio Pharma Total Debt / Capital for the quarter ending June 06, 2010 was $2m a -688.77% decrease of -13m year over year
  • Inovio Pharma Other Liabilities for the quarter ending December 12, 2018 was $9m a -4.71% decrease of 0m year over year
  • Inovio Pharma Total Debt / Equity for the quarter ending June 06, 2010 was $2m a -811.12% decrease of -16m year over year
View Chart On Koyfin

Quarterly INO Net Debt / EBITDA Data

06/2020$2m
03/2020$2m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$1m
09/2018$1m
06/2018$6m
03/2018$1m

Annual INO Net Debt / EBITDA Data

2019$0m
2018$1m
2017$2m
2016$1m
2015$5m
2014$2m
2013$3m
2012$1m
2011$1m
2010$1m